Company Filing History:
5 out of 115 
5 out of 517 
2 out of 192 
Years Active: 2018-2021
Title: Frank Tomaka: Innovator in HIV Research
Introduction
Frank Tomaka is a notable inventor based in Titusville, NJ (US), recognized for his significant contributions to the field of immunology, particularly in the development of vaccines against human immunodeficiency virus (HIV) infection. With a total of five patents to his name, Tomaka has made strides in enhancing protective immunity against HIV.
Latest Patents
Among his latest patents, Tomaka has developed compositions and methods for inducing protective immunity against HIV infection. These innovations include heterologous vaccine combinations utilizing adenovirus 26 vectors for priming immunization, alongside isolated HIV antigenic polypeptides combined with modified vaccinia virus (MVA) vectors for boosting immunization. This approach has shown promise in inducing strong protective immunity against various clades of HIV. Additionally, he has described methods for inducing an immune response in HIV-infected subjects undergoing antiretroviral treatment. These methods involve administering an adenovirus vector primer vaccine and an MVA vector booster vaccine that encodes mosaic HIV antigens.
Career Highlights
Throughout his career, Frank Tomaka has worked with prominent organizations such as Janssen Vaccines & Prevention B.V. and Beth Israel Deaconess Medical Center, Inc. His work in these institutions has been pivotal in advancing research and development in the field of HIV vaccines.
Collaborations
Tomaka has collaborated with esteemed colleagues, including Dan H. Barouch and Johanna Schuitemaker, further enhancing the impact of his research through shared expertise and innovative ideas.
Conclusion
Frank Tomaka's contributions to HIV research and vaccine development underscore his role as a leading inventor in the field. His innovative approaches and collaborations continue to pave the way for advancements in protective immunity against HIV infection.